University of Wisconsin-Madison Department of Pathology and Laboratory Medicine
 Home Research People Publications
Wang Lab Home > Publications      

  Recent Publications

  1. Wang SQ, Simon BP, Bennett DA, Schneider JA, Malter JA and Wang DS: The significance of Pin1 in the development of Alzheimer’s disease, J Alzheimer’s Dis 2007;11 (1): (13-23).

  2. Wang DS, Malter JS, Dickson DW: Aß degradation and Alzheimer’s disease. J Biomed Biotechnol. 2006;2006(3):58406.

  3. Fujino Y, Wang DS, Dickson WD: A new specific 4R tau antibody, ET-3, is useful for detecting Argyrophilic grain disease in Alzheimer’s disease. J Neuropathol Exp Neurol. 64:209-214; 2005.

  4. Uchikado H, Shaw G, Wang DS, Dickson DW: Screening for neurofilament inclusion disease (NFID) using α-internexin immunohistochemistry, Neurology 2005;64(9):1658-9.

  5. Mott RT, Dickson WD, Ervin JF, Trojanowski JQ, Lee VM, Forman M, Deerlin VV, Schmechel DE, Wang DS, Corral A, Hulette CM: Neuropathological, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol 2005 May;64(5):420-8.

  6. Wang DS, Lipton R, Davies P, Younkin SG, Eckman C, Dickson D: Decreased neprilysin in frontal gray matter in Alzheimer’s disease, but not in pathological aging. J Neuropathol Exp Neurol 64(5):378-85, 2005.

  7. Wang DS, Bennett DA, Mufson E, Cochran E, Dickson DW: Decreases in soluble α-synuclein in frontal cortex correlate with cognitive decline in the elderly. Neurosci Lett 359; (1-2): 104-108;2004;

  8. Waghray A, Wang DS, McKinsey D, Hayes RL, Wang KKW: Molecular Cloning and Characterization of Rat Calpain-5. Biochem Biophys Res Comm 324:46-51;2004.

  9. Farrer M, Forno L, Lincoln S, Wang DS, Hulihan M, Kachergus J, Maraganore DM, Hardy J, Gwinn-Hardy K, Dickson D, Langston WJ: Comparison of kindreds with familial Lewy body disease and α-synuclein genomic multiplications. Annals of Neurology 2004;55:174-179.

  10. Wang DS, Bennett DA, Mufson E, Cochran E, Dickson DW. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res 48(1): 93-100;2004.

  11. Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW: Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol. 62(4):389-97; 2003.

  12. Wang DS: From Lewy Body Disease to Alzheimer’s Disease: Hypothesis and Evidence. Frontiers in Bioscience 8: s223-227;2003.

  13. Wang DS, Iwata N, Hama E, Saido TC, Dickson DW: Oxidized neprilysin in aging and Alzheimer’s disease brains. Biochem Biophys Res Comm 310: 236-241;2003.

  14. McGreevy K, Wang DS, Dickson DW. Is lowering amyloid levels a therapeutic target for Alzheimer’s disease? Insights from macrophage-mediated resorption of amyloid in cortical infarcts. In: Iqbal K, Winblad B, eds. Alzheimer's Disease and Related Disorders: Research Advances, Ana Aslan Intl Acad Aging, Bucharest, Romania, pp. 560-572, 2003

  15. Wang DS, Cochran E, Bennett D, Mufson E, Eckman S, Dickson DW: Amyloid, PHF-tau, ubiquitin and synaptic markers in the progression of Alzheimer’s disease: immunochemical analyses of frontal cortex from prospectively studied elderly humans. In: Iqbal K, Sisodia SS, Winblad B (eds.) Alzheimer’s Disease: Advances in Etiology, Pathogenesis and Therapeutics. John Wiley & Sons, Ltd, West Sussex, 2001, pp. 166-180.
Pathology Home | UW Home | Site Map
File last updated: March 7, 2007 
Feedback, questions or accessibility issues: webmaster@pathology.wisc.edu
Copyright© 2002-2006 The Board of Regents of the University of Wisconsin System.